Hikma Bolsters Injectable Portfolio With $375M Custopharm Acquisition
Hikma Pharmaceuticals Plc (OTC:HKMPF) has agreed to acquire US-based generic sterile injectables producer Custopharm Inc from Water Street Healthcare Partners. Hikma will pay an…